Heparin-induced thrombocytopenia in the cardiovascular patient: Diagnostic and treatment guidelines

European Journal of Cardio-thoracic Surgery

Volumn 27, Issue 1, 2005, Pages 138-149

  Gurbuz, Ahmet Tayfun ^a,b   Elliott, William G ^a   Zia, Ayhan A ^a  

^a Tucson Med Center   (United States)

^b S Arizona Cardio Thoracic Surgery   (United States)

Author keywords

Heparin; Thrombocytopenia; Thrombosis

Indexed keywords

ABCIXIMAB; ANCROD; ARGATROBAN; DANAPAROID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; IMMUNOGLOBULIN; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; TIROFIBAN;

BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CROSS REACTION; DRUG ACTIVITY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN BLOOD LEVEL; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOREACTIVITY; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; THROMBOCYTE ACTIVATION; THROMBOSIS;

ANCROD; ANTIBODIES; ANTICOAGULANTS; CARDIOVASCULAR DISEASES; CHONDROITIN SULFATES; DERMATAN SULFATE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPARITIN SULFATE; HIRUDIN THERAPY; HIRUDINS; HUMANS; PEPTIDE FRAGMENTS; PIPECOLIC ACIDS; PRACTICE GUIDELINES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECOMBINANT PROTEINS; THROMBIN;

EID: 11144257768     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.09.021     Document Type: Review

References (100)

1. J. McLean The thromboplastic action of cephalin Am J Physiol 41 1916 250 257
2. R.E. Weisman, and R.W. Tobin Arterial embolism occurring during systemic heparin therapy AMA Arch Surg 76 1958 219 227
3. B. Roberts, F.E. Rosato, and E.F. Rosato Heparin - a cause of arterial emboli Surgery 55 1964 803 808
4. G.R. Rhodes, R.H. Dixon, and D. Silver Heparin-induced thrombocytopenia with thrombotic and hemorrhagic manifestations Surg Gynecol Obstet 136 1973 409 416
5. J. Ansell, and D. Deykin Heparin-induced thrombocytopenia and recurrent thromboembolism Am J Hematol 8 1980 325 332
6. B.H. Chong Heparin-induced thrombocytopenia Br J Haematol 89 1995 431 439
7. B.H. Chong, and P.A. Castaldi Platelet pro-aggregating effects of heparin: possible mechanism for non-immune heparin associated thrombocytopenia Aust NZ J Med 16 1986 715 716
8. M.R. Kibbe, and R.Y. Rhee Heparin-induced thrombocytopenia: pathophysiology Semin Vasc Surg 9 1996 284 291
9. T.E. Warkentin, B.H. Chong, and A. Greinacher Heparin-induced thrombocytopenia: towards consensus Thromb Haemost 79 1998 1 7
10. B.K. Phelen Heparin-associated thrombosis without thrombocytopenia Ann Intern Med 99 1983 637 638
11. V. Hach-Wunderle, K. Kainer, B. Krug, G. Muller-Berghaus, and B. Potzsch Heparin-associated thrombosis despite normal platelet counts Lancet 344 1994 469 470
12. R.L. Singer, J.D. Mannion, T.L. Bauer, F.R. Armenti, and R.N. Edie Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass Chest 104 1993 1436 1440
13. J. Amiral, F. Bridey, M. Dreyfus, A.M. Vissoc, E. Fressinaud, M. Wolf, and D. Meyer Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95 96
14. J. Amiral, F. Bridey, M. Wolf, C. Boyer-Neumann, E. Fressinaud, A.M. Vissac, E. Peynaud-Debayle, M. Dreyfus, and D. Meyer Antibodies to macromolecular platelet factor-4 heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases Thromb Haemost 73 1995 21 28
15. J. Suh, M. Malik, and G. Visentin Characterization of the humoral immune response in heparin-induced thrombocytopenia Am J Hematol 54 1997 196 201
16. B.H. Chong, I. Fawaz, C.N. Chesterman, and M.C. Berndt Heparin-induced thrombocytopenia: mechanism of interaction of the heparin dependent antibody with platelets Br J Haematol 73 1989 235 240
17. B.H. Chong, B. Murray, M.C. Behrendt, L.C. Dunlop, T. Brighton, and C.N. Chesterman Plasma P selectin is increased in thrombotic consumptive platelet disorder Blood 83 1994 1535 1541
18. T.E. Warkentin, M.N. Levine, J. Hirsh, P. Horsewood, R.S. Roberts, M. Gent, and J.G. Kelton Heparin-induced thrombocytopenia in patients treated with low molecular-weight heparin or unfractionated heparin N Eng J Med 332 1995 1330 1335
19. W.R. Bell, and R.M. Royall Heparin-induced thrombocytopenias. Comparison of three heparin preparations N Eng J Med 303 1980 902 907
20. J. Amiral Diagnostic tests in heparin-induced thrombocytopenia Platelets 8 1997 68 72
21. T.E. Warkentin Clinical presentation of heparin-induced thrombocytopenia Semin Hematol 35 (4)5 Suppl 1998 9 16
22. A. Greinacher, P. Eichler, N. Lubenow, J. Kwasny, and M. Luz Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range Blood 96 2000 846 851
23. T.E. Warkentin, J.I. Sheppard, P. Horsewood, P.J. Simpson, J.C. Moore, and J.G. Kelton Impact of patient population on the risk for heparin-induced thrombocytopenia Blood 96 2000 1703 1708
24. T.E. Warkentin, and J.G. Kelton A 14 year study of heparin-induced thrombocytopenia Am J Med 101 1996 502 507
25. J.T. Walls, J.J. Curtis, D. Silver, T.M. Boley, R.A. Schmaltz, and R.N. Nawarawong Heparin-induced thrombocytopenia in open heart surgical patients. Sequel of late recognition Ann Thorac Surg 53 1992 787 791
26. Y. Glock, E. Szmil, B. Boudjema, H. Boccalon, G. Fournial, A.L. Cerene, and P. Puel Cardiovascular surgery and heparin-induced thrombocytopenia Int Angiol 7 1988 238 245
27. M. Trossaert, A. Gaillard, P.L. Commin, J. Amiral, A.M. Vissac, and E. Fressinaud High incidence of anti-heparin/platelet factor 4 antibodies after cardiolpulmonary bypass surgery Br J Haematol 101 1998 653 655
28. C. Pouplard, M.A. May, S. Iochmann, J. Amiral, A.M. Vissac, M. Marchand, and Y. Gruel Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia Circulation 99 1999 2530 2536
29. J.L. Francis, G.J. Palmer, R. Moroose, and A. Drexler Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery Ann Thorac Surg 75 2003 17 22
30. T.E. Warkentin, and C.S. Sigouin Gender and risk of immune heparin-induced thrombocytopenia Blood 100 2002 17a
31. N. Lubenow, R. Kempf, A. Eichner, P. Eichler, L.E. Carlsson, and A. Greinacher Heparin-induced thrombocytopenia. Temporal pattern of thrombocytopenia in relation to initial use of re-exposure to heparin Chest 122 2001 37 42
32. T.E. Warkentin, and J.G. Kelton Temporal aspects of heparin-induced thrombocytopenia N Eng J Med 344 2001 1286 1292
33. J. Laster, D. Cikrit, N. Walker, and D. Silver The heparin-induced thrombocytopenia syndrome. An update Surgery 102 1987 763 770
34. J.M. Walenga, W.P. Jeske, A.R. Fasanella, J.J. Wood, and M. Bakhos Laboratory tests for the diagnosis of heparin-induced thrombocytopenia Semin Thromb Hemost 25 Suppl I 1999 43 49
35. P.E. Stanton, J.R. Evans, A.A. Lefemine, N.M. Vo, G.A. Rannick, C.V. Morgan Jr., P.J. Hinton, and M. Read White clot syndrome South Med J 81 1988 616 620
36. J.C. Liu, B.E. Lewis, L.H. Steen, E.D. Grassman, M. Bakhos, B. Blakeman, L. Wrona, and F. Leya Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopenia Am J Cardiol 89 2002 979 981
37. R.G. Makhoul, C.S. Greenberg, and R.L. McCann Heparin associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution J Vasc Surg 4 1986 522 528
38. A.P. Hong, D.J. Cook, C.S. Sigouin, and T.E. Warkentin Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia Blood 101 2003 3049 3051
39. L.K. Boshkov, T.E. Warkentin, C.P.M. Hayward, M. Andrew, and J.G. Kelton Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies Br J Haematol 84 1993 322 328
40. D.J. King, and J.G. Kelton Heparin-associated thrombocytopenia Ann Intern Med 100 1984 535 540
41. T.E. Warkentin Heparin-induced skin lesions Br J Haematol 92 1996 494 497
42. D.E. Wallis, D.L. Workman, B.E. Lewis, L. Steen, R. Piffare, and J.F. Moran Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia Am J Med 106 1999 629 635
43. J. Laster, R. Efrink, and D. Silver Reexposure to heparin of patients with heparin associated antibodies J Vasc Surg 9 1989 677 682
44. D. Sheridan, C. Carter, and J.G. Kelton A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
45. B.H. Chong, J. Burgess, and F. Ismail The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia Thromb Haemost 81 1993 988 993
46. A. Greinacher, J. Amiral, V. Dummel, A. Vissac, V. Kiefel, and C. Mueller-Eckhardt Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test and platelet factor 4/heparin enzyme immunosorbent assay Transfusion 34 1994 381 385
47. P. Eichler, R. Raschke, N. Lubenow, O. Meyer, P. Schwind, and A. Greinacher The new ID-heparin/PF4 antibody test for rapid detection of heparin-induced antibodies in comparison with functional and antigenic assays Br J Haematol 116 2002 887 891
48. C.B. Granger, J.M. Miller, E.G. Bovill, A. Gruber, R.P. Tracy, M.W. Krucoff, C. Green, E. Berrios, R.A. Harrington, E.M. Ohman, and R.M. Califf Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes Circulation 91 1995 1929 1935
49. A. Greinacher, I. Michels, and C. Mueller-Eckhardt Heparin-associated thrombocytopenia: the antibody is not heparin specific Thromb Haemost 67 1992 545 549
50. J. Leroy, M.H. Leclerc, B. Delahousse, C. Guerois, P. Foloppe, Y. Gruel, and F. Toulemonde Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY216) Semin Thromb Hemost 11 1985 326 329
51. A.K. Ganjoo, M.G. Harloff, and D. Johnson Cardiopulmonary bypass for heparin-induced thrombocytopenia: management with a heparin-bonded circuit and enoxaparin J Thorac Cardiovasc Surg 112 1996 1390 1392
52. D.G. Muelman Orgaran (Org 10172): its pharmacologic profile in experimental models Haemostasis 22 1992 65 68
53. T.E. Warkentin Limitations of conventional treatment options for heparin-induced thrombocytopenia Semin Hematol 35 Suppl 5 1998 17 25
54. B.H. Chong, F. Ismail, J. Cade, A.S. Gallus, S. Gordon, and C.N. Chesterman Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid Org 10172 Blood 73 1989 1592 1596
55. J. Harenberg, R. Zimmermann, F. Schwarz, and W. Kubler Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid Lancet 1 1983 986 987
56. T.L. Ortel, and B.H. Chong New treatment options for heparin-induced thrombocytopenia Semin Hematol 35 Suppl 5 1998 26 34
57. T.L. Ortel, J.P. Gockerman, R.M. Califf, R.L. McCann, C.M. O'Connor, D.M. Metzler, and C.S. Greenberg Parenteral anticoagulation with the heparinoid Lomaparan (Org 10172) in patients with heparin-induced thrombocytopenia and thrombosis Thromb Haemost 67 1992 292 296
58. T.E. Warkentin Danaproid (Orgaran) for the treatment of heparin-induced thrombocytopenia (HIT) and thrombosis: effects of in vivo thrombin and cross-linked fibrin generation, and evaluation of the clinical significance of in vitro cross-reactivity (XR) of danaproid for HIT-IgG Blood 88 Suppl Abstr 1996 626a
59. H.N. Magnani, R.J.R. Beijering, J.W. Ten Cate, and B.H. Chong Orgaran anticoagulation for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia R. Pifarre New anticoagulants for the cardiovascular patient 1997 Hanley and Belfus, Inc. Philadelphia, PA 487 500
60. S.D. Gitlin, G.M. Deeb, C. Yann, and A.H. Schmaier Intraoperative monitoring of danaproid sodium anticoagulation during cardiovascular operations J Vasc Surg 27 1998 568 575
61. D.G. Meuleman Orgaran (ORG 10172). Its pharmacologic profile in experimental models Haemostasis 22 1992 58 64
62. M. Carrier, D. Robitaille, L.P. Perrault, M. Pellerin, P. Page, R. Cartier, and D. Bouchard Heparin versus danaproid in off-pump coronary bypass grafting: results of a prospective randomized clinical trial J Thorac Cardiovasc Surg 125 2003 325 329
63. W.R. Bell, W.R. Pitney, and J.F. Goodwin Therapeutic defibrination in the treatment of thrombotic disease Lancet 1 1968 490 493
64. S.J. Teasdale, V.J. Zulys, T. Mycyk, R.J. Baird, and M.F.X. Glynn Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis Ann Thorac Surg 48 1989 712 713
65. F. Markward Hirudin: the promising antithrombotic Cardiovasc Drug Rev 10 1992 211 232
66. J.I. Weitz, M. Huboda, D. Massel, J. Margarone, and J. Hirsh Clot bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J Clin Invest 86 1990 385 391
67. A. Greinacher, U. Janssens, G. Berg, G. Bock, H. Kwasny, B. Kemkes-Matthes, P. Eichler, H. Volpel, B. Potzsch, and M. Luz Lepirudin (Recombinant Hirudin) for anticoagulation in patients with heparin-induced thrombocytopenia Circulation 100 1999 587 593
68. A. Greinacher, H. Volpel, U. Janssens, V. Hach-Wunderle, B. Kemkes-Matthes, P. Eichler, H.G. Mueller-Velten, and B. Potzsch Recombinant hirudin (lepirudin) provides effective and safe anticoagulation in patients with heparin-induced thrombocytopenia type II: a prospective study Circulation 99 1999 73 80
69. B. Potzsch, S. Iversen, F.C. Riess, N. Tzanova, C. Seelig, G. Nowak, and G. Muller-Berghaus Recombinant hirudin as an anticoagulant in open-heart surgery: a case report Ann Hematol 68 Suppl 2 1993 A46
70. F.C. Riess, B. Potzsch, R. Bader, N. Bleese, A. Greinacher, C. Lower, K. Madlener, and G. Muller-Berghaus A case report on the use of recombinant hirudin as an anticoagulant for cardiopulmonary bypass in open heart surgery Eur J Cardiothorac Surg 10 5 1996 386 388
71. B. Potzsch, K. Madlener, C. Seelig, C.F. Riess, A. Greinacher, and G. Muller-Berghaus Monitoring r-hirudin anticoagulation during cardiopulmonary bypass-assessment of the whole blood ecarin time Thromb Haemost 77 1997 920 925
72. X.H. Song, G. Huhle, L. Wang, U. Hoffmann, and J. Harenberg Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin Circulation 100 1999 1528 1532
73. J.M. Walenga, R. Pifarre, and J. Fareed Recombinant hirudin as an anti-thrombotic agent Drugs Future 15 1990 267 280
74. A. Koster, F. Merkle, R. Hansen, M. Loebe, H. Kuppe, R. Hetzer, G.J. Crystal, and F. Mertzlufft Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systems Anesth Analg 91 2000 265 269
75. L.R. Bush Argatroban: a selective potent thrombin inhibitor Cardiovasc Drug Rev 9 1991 247 263
76. D. Callas, and J. Fareed Comparative pharmacology of site directed antithrombin agents. Implications in drug development Thromb Haemost 74 1995 473 481
77. C.N. Berry, C. Girardot, C. Lecoffre, and C. Lunven Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot incorporated thrombin: comparison with heparin and recombinant hirudin Thromb Haemost 72 1994 381 386
78. B.E. Lewis, J.M. Walenga, and D.E. Wallis Anticoagulation with Novastan (Argatroban) in patients with heparin-induced thrombocytopenia and thrombosis syndrome Semin Thromb Hemost 23 1997 197 202
79. B.E. Lewis, D.E. Wallis, S.D. Berkowitz, W.H. Matthai, J. Fareed, J.M. Walenga, J. Bartholomew, R. Sham, R.G. Lerner, Z.R. Zeigler, P.K. Rustagi, I.K. Jang, S.D. Rifkin, J. Moran, M.J. Hursting, and J.G. Kelton ARG-911 study investigators. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia Circulation 103 2001 1838 1843
80. B.E. Lewis, D.E. Wallis, F. Leya, M.J. Hursting, and J.G. Kelton Argatroban anticoagulation in patients with heparin-induced thrombocytopenia Arch Intern Med 163 2003 1849 1856
81. S.B. Sheth, R.A. DiCicco, M.J. Hursting, T. Montague, and D.K. Jorkasky Interpreting the international normalized ratio (INR) in individuals receiving argartoban and warfarin Thromb Haemost 85 2001 435 440
82. B. Lewis, M. Cohen, J. Moses, and W. Matthai Argatroban anticoagulation during initial and repeat percutaneous coronary intervention in patients with heparin-induced thrombocytopenia [abstr] Am J Cardiol 86 Suppl 8A 2000 14i
83. B.E. Lewis, and J.M. Walenga Argatroban in HITT II and acute coronary syndrome Pathophysiol Heamost Thromb 32 Suppl 3 2002 46 55
84. K. Furukawa, H. Ohteki, K. Hirahara, Y. Narita, and S. Koga The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations J Thorac Cardiovasc Surg 122 2001 1255 1256
85. D.R. Kieta, A.T. McCammon, W.L. Holman, and V.G. Nielsen Hemostatic analysis of a patient undergoing off-pump coronary artery bypass surgery with argatroban anticoagulation Anesth Analg 96 2003 956 958
86. M.A. Cannon, J. Butterworth, R.D. Riley, and J.M. Hyland Failure of argatroban during off-pump coronary artery bypass surgery Ann Thorac Surg 77 2004 711 713
87. T.M. Sciulli, and V.F. Mauro Pharmacology and clinical use of bivalirudin Ann Pharmacother 36 2002 1028 1041
88. A.M. Lincoff, J.A. Bittl, N.S. Kleiman, I.J. Sarembock, J.D. Jackman, S. Mehta, M.A. Tannenbaum, A.L. Niederman, W.B. Bachinsky, J. Tift-Mann, H.G. Parker, G.J. Kereiakes, R.A. Harrington, F. Feit, E.S. Maierson, D.P. Chew, and E.J. Topol Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the randomized evaluation of PCI Linking Angiomax to reduced clinical events. [Replace]-1 Trial) Am J Cardiol 93 2002 1092 1096
89. T.E. Warkentin Heparin-induced thrombocytopenia: pathogenesis and management Br J Haematol 121 2003 535 555
90. B.D. Spiess, A. DeAnda, A. McCarthy, D. Yeatman, H.L. Harness, and G. Katlaps Off pump CABG in a patient with bivalirudin: a case report Anesth Analg 93 2002 SCA70
91. J.C. Vasquez, A. Vichiendilokkul, S. Mahmood, and F.A. Baciewicz Jr. Anticoagulation with bivaluridin during cardiopulmonary bypass in cardiac surgery Ann Thorac Surg 74 2002 2177 2179
92. Z. Davis, R. Anderson, D. Short, D. Garber, and A. Valgiusti Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass Ann Thorac Surg 75 2003 264 265
93. A.F. Merry, P. Raudkivi, N.G. Middleton, J.M. McDougall, P. Nand, B.P. Mills, B.J. Webber, C.M. Frampton, and H.D. White Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery Ann Thorac Surg 77 3 2004 925 931
94. A. Greinacher, U. Liebenhoff, V. Kiefel, P. Presek, and C. Mueller-Eckhardt Heparin associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation - a possible new indication for high dose i.v. IgG Thromb Haemost 71 1994 641 645
95. E. Grau, M. Linares, M.A. Olaso, J. Ruvira, and J. Sanchis Heparin-induced-thormbocytopenia-response to intravenous immunoglobulin in vivi and in vitro Am J Hematol 39 1992 312 313
96. A.T. Nurden, J. Laroche-Traineau, V. Jallu, J. Broult, C. Durrieu, P. Besse, C. Brossel, and P. Hourdille Heparin-induced thrombocytopenia: observation of the nature of the antibody activities and on the use of gammaglobulin concentrates in a patient with thrombotic complications Thromb Haemost 65 1991 796
97. J. Brady, J.A. Riccio, O.H. Yumen, A.Z. Makary, and S.M. Greenwood Plasmapheresis: a therapeutic option in the management of heparin-induced thrombocytopenia with thrombosis Am J Clin Pathol 96 1991 394 397
98. M. Contreras The appropriate use of platelets: an update from the Edinburgh Consensus Conference Br J Haematol 101 1998 10 12
99. A. Koster, O. Meyer, T. Fischer, M. Kukucka, T. Krabatsch, M. Bauer, H. Kuppe, and R. Hetzer One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II J Thorac Cardiovasc Surg 122 2001 1254 1255
100. G.N. Olinger, C.V. Hussey, J.A. Olive, and M.I. Malik Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation J Thorac Cardiovasc Surg 87 1984 673 677